Journal article
The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
- Abstract:
- Key Clinical Message: In infants, especially with novel previously undescribed mutations of the KATP channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if the expected response is not observed.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 353.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/ccr3.370
Authors
- Publisher:
- John Wiley and Sons Ltd
- Journal:
- Clinical Case Reports More from this journal
- Volume:
- 3
- Issue:
- 10
- Pages:
- 884-887
- Publication date:
- 2015-10-01
- DOI:
- ISSN:
-
2050-0904
- Keywords:
- Pubs id:
-
pubs:547025
- UUID:
-
uuid:68db3771-0d07-408d-a8bb-e56a03f5eb6c
- Local pid:
-
pubs:547025
- Source identifiers:
-
547025
- Deposit date:
-
2015-11-26
Terms of use
- Copyright holder:
- O'Connell et al
- Copyright date:
- 2015
- Notes:
-
Copyright © 2015 The Authors. Clinical Case Reports published by John Wiley and Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
If you are the owner of this record, you can report an update to it here: Report update to this record